Hemodialysis vs. Peritoneal Dialysis: Choosing the Right Treatment for End‑Stage Renal Disease

For most patients, hemodialysis and peritoneal dialysis provide comparable outcomes for end‑stage renal disease (ESRD). Individual health status, personal preferences, and cost considerations often guide the final choice.

When kidney function declines to the point where the organs can no longer filter waste—a condition known as ESRD—a nephrologist will discuss dialysis options. Many patients are unaware that they can select from more than one dialysis modality.

Hemodialysis is the most widely used modality. Yet a 2024 patient survey revealed that over 50 % of respondents felt insufficiently informed about peritoneal dialysis, a less common but equally effective alternative.

Read on to understand the key differences between hemodialysis and peritoneal dialysis, the advantages and drawbacks of each, and the factors you should weigh when deciding.

Hemodialysis employs a machine called a dialyzer (often referred to as an “artificial kidney”) to filter blood outside the body. After filtration, the clean blood is returned to the patient.

Because blood must leave and re‑enter the circulatory system, hemodialysis requires a vascular access point. Most patients undergo a minor surgery to create an arteriovenous (AV) fistula or AV graft in the arm; a temporary central venous catheter may be used when short‑term access is needed.

Typical treatment involves 3‑ to 4‑hour sessions three times per week at a dialysis center. Home hemodialysis is also an option, offering greater scheduling flexibility.

While on dialysis, patients must follow a renal‑specific diet—generally higher in protein and lower in sodium and fluids—under the guidance of a renal dietitian.

Common hemodialysis side effects include itchy skin, muscle cramps, and occasional low blood pressure (hypotension). Some patients also experience allergic reactions to the dialyzer material.

Peritoneal dialysis uses the lining of the abdomen (the peritoneum) as a natural filter, allowing waste removal inside the body.

A surgeon places a soft catheter into the abdominal cavity before treatment begins. During each exchange, sterile dialysis fluid is infused through the catheter, dwells for 4–6 hours, and is then drained, carrying waste with it.

Patients typically perform 3–5 exchanges daily. Continuous ambulatory peritoneal dialysis (CAPD) requires no machine, while automated peritoneal dialysis (APD) uses a cycler to perform exchanges while the patient sleeps.

Dietary restrictions are generally less severe than with hemodialysis, and patients may have more flexibility in food choices.

Peritoneal dialysis side effects differ; patients may experience weight gain or elevated blood glucose, especially when glucose‑based solutions are used. Nonglucose solutions such as icodextrin can mitigate this issue.

Serious complications include abdominal hernias and peritonitis (infection of the peritoneal lining). Meticulous catheter care and proper technique dramatically reduce infection risk.

Continuous vs. Automated Peritoneal Dialysis

CAPD is performed manually throughout the day without equipment. APD employs a bedside machine that automatically cycles fluid while the patient sleeps. A peritoneal equilibrium test helps determine the optimal exchange frequency and whether CAPD or APD best matches the patient’s needs.

Key factors that often influence the choice between hemodialysis and peritoneal dialysis include:

• Work and personal schedule
• Availability of a supportive caregiving network
• Need and ability to travel
• Comfort with self‑administration of treatment
• Home environment and space for equipment storage
• Financial resources and insurance coverage

Patients can switch modalities later if circumstances change.

Medical contraindications may limit options. Hemodialysis is not feasible when reliable vascular access cannot be established, such as in severe peripheral vascular disease or certain clotting disorders.

Peritoneal dialysis is generally avoided in patients with:

• Unrepaired abdominal wall hernia
• Pleuroperitoneal shunt
• Extensive intra‑abdominal adhesions from prior surgery

Although hemodialysis remains the predominant treatment, both modalities are equally effective. A 2018 comparative study found no difference in overall survival between the two techniques.

A 2023 analysis suggested that peritoneal dialysis may offer additional benefits, including more stable blood pressure, better clearance of urea and albumin, and greater preservation of residual kidney function.

Ultimately, the most appropriate modality depends on the individual’s medical profile, lifestyle, and personal goals.

Cost varies by insurance type and coverage. In the United States, most ESRD patients qualify for Medicare, which pays roughly 80 % of dialysis expenses. Medicare coverage typically begins on the first day of the fourth month of treatment, but it can be back‑dated to month one for patients who start home dialysis under specific criteria.

As of 2025, the Medicare base rate for a dialysis session is $273.82, though private insurers often reimburse at higher rates. Peritoneal dialysis generally incurs lower overall costs than in‑center hemodialysis.

Both hemodialysis and peritoneal dialysis are life‑sustaining, evidence‑based therapies for ESRD. While hemodialysis is more common, peritoneal dialysis may provide greater flexibility and cost advantages for many patients.